About: Dasotraline

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Dasotraline (INN; former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder (BED). Structurally, dasotraline is a stereoisomer of desmethylsertraline (DMS), which is an active metabolite of the marketed selective serotonin reuptake inhibitor (SSRI) antidepressant sertraline (Zoloft).

Property Value
dbo:abstract
  • Dasotraline (INN; former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder (BED). Structurally, dasotraline is a stereoisomer of desmethylsertraline (DMS), which is an active metabolite of the marketed selective serotonin reuptake inhibitor (SSRI) antidepressant sertraline (Zoloft). (en)
dbo:casNumber
  • 675126-05-3
dbo:chEMBL
  • 3301595
dbo:fdaUniiCode
  • 4D28EY0L5T
dbo:kegg
  • D10700
dbo:pubchem
  • 9947999
dbo:thumbnail
dbo:wikiPageID
  • 22604651 (xsd:integer)
dbo:wikiPageLength
  • 7719 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082355600 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 16 (xsd:integer)
dbp:casNumber
  • 675126 (xsd:integer)
dbp:chembl
  • 3301595 (xsd:integer)
dbp:chemspiderid
  • 8123611 (xsd:integer)
dbp:cl
  • 2 (xsd:integer)
dbp:h
  • 15 (xsd:integer)
dbp:iupacName
  • -4 (xsd:integer)
dbp:kegg
  • D10700 (en)
dbp:n
  • 1 (xsd:integer)
dbp:pubchem
  • 9947999 (xsd:integer)
dbp:smiles
  • C1C[C@H]N (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • SRPXSILJHWNFMK-MEDUHNTESA-N (en)
dbp:unii
  • 4 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 449042592 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:width
  • 200 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Dasotraline (INN; former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder (BED). Structurally, dasotraline is a stereoisomer of desmethylsertraline (DMS), which is an active metabolite of the marketed selective serotonin reuptake inhibitor (SSRI) antidepressant sertraline (Zoloft). (en)
rdfs:label
  • Dasotraline (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License